First GPCR-directed antibody passes approval milestone

First GPCR-directed antibody passes approval milestone, Published online: 28 June 2018; doi:10.1038/nrd.2018.103

Amgen's erenumab recently secured FDA approval as the first G protein-coupled receptor-targeted antibody. More of these biologics are on the way, despite remaining challenges.

中文翻译：

---

第一款针对GPCR的抗体通过批准里程碑

第一款针对GPCR的抗体通过批准里程碑

首个GPCR定向抗体通过了批准里程碑，在线发布：2018年6月28日; doi：10.1038 / nrd.2018.103

Amgen的erenumab最近获得了FDA的批准，成为首个G蛋白偶联受体靶向抗体。尽管仍然存在挑战，但更多的此类生物制剂仍在生产中。